Articles Mentioning Life Sciences Tools and Services Stocks

Results 41 - 50 of 329 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services

Investing | January 10, 2015

In Case You Missed it, This New Cancer Study is Terrifying

A terrifying new cancer study out of Johns Hopkins Medicine confirms a suspicion some researchers have harbored all along.

Investing | January 07, 2015

Why Sequenom, Inc. Stock Scorched 23% Higher in December

Sequenom decodes its way to big gains in December after settling a long-standing dispute with a larger rival. See what this could mean for investors over the long run.

Investing | December 21, 2014

5 Crazy Habits You Might Adopt With Low-Cost Genome Sequencing

A full human genome can now be sequenced for $1,000. That's still a little pricey for mass adoption, but Illumina and Pacific Biosciences could bring the cost down even further -- opening up the genomics floodgates.

Investing | December 03, 2014

Why Sequenom, Inc. Stock Skyrocketed

Sequenom splices and dices its ways to huge gains after announcing the settlement of a long-standing patent dispute with a rival.

Investing | October 24, 2014

Pacific Biosciences of California Earnings Rocket Higher on Roche Deal

What investors need to know about Pacific Biosciences' third quarter performance.

Investing | October 23, 2014

3 Reasons Thermo Fisher Scientific Inc.'s Stock Could Rise

Thermo Fisher Scientific's future rests on three pillars of growth, and a big-name acquisition may tip the scales in their favor.

Investing | September 29, 2014

3 Reasons Illumina, Inc.'s Stock Could Fall

Illumina (ILMN) seems unbeatable in sequencing today, but tomorrow could bring changes no one can anticipate.

Investing | September 23, 2014

3 Reasons Illumina, Inc.'s Stock Could Rise

It's the leader in a fast-growing young industry, but does Illumina (ILMN) have what it takes to trounce the market over the long term?

Investing | June 30, 2014

Why Are Companion Diagnostics So Important?

Patients, doctors, and investors have been excited about new frontiers in oncology, but can these drugs be useful without companion diagnostics?

Investing | June 24, 2014

Will Danaher Corporation Bounce Back With a Big Buyout?

M&A's been the biggest trend of health care in 2014, but Danaher's been notably quiet. Will this acquisitions king jump into the game this year?

Results 41 - 50 of 329 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services